tech
Novo Hands Over Parkinson’s Therapy to Zuckerberg-Backed Startup
Novo Nordisk A/S agreed to hand over an experimental therapy for Parkinson’s disease to a Mark Zuckerberg-backed AI startup to potentially speed its development.
Read full story on Bloomberg Tech → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop